Skip to content

TO STUDY THE UTILITY OF RUBRICS FROM SYNTHESIS REPERTORY VERSION 9.1 IN THE MANAGEMENT OF GENERALIZED ANXIETY DISORDER IN THE AGE GROUP OF 18 – 35 YEARS

TO STUDY THE UTILITY OF RUBRICS FROM SYNTHESIS REPERTORY VERSION 9.1 BY Dr.FREDERICK SCHROYENS IN THE MANAGEMENT OF GENERAIZED ANXIETY DISORDER IN THE AGE GROUP OF 18 - 35 YEARS - AN EXPERIMENTAL NON CONTROLLED STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096052
Enrollment
34
Registered
2025-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: TO STUDY THE UTILITY OF RUBRICS FROM SYNTHESIS REPERTORY VERSION 9.1 BY Dr FREDERICK SCHROYENS IN THE MANAGEMENT OF GENERALIZED ANXIETY DISORDER IN THE AGE GROUP OF 18 to 35 YEARS to

Sponsors

DR SURBHI OHAL
Lead Sponsor
DR UTTARA AGALE
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group 18yrs – 35yrs. Patients of all Gender. Clinically diagnosed patients of Generalized Anxiety Disorder. Mild and Mild to Moderate Severity of Generalized Anxiety Disorder which scores 0 to 24 on Hamilton Anxiety Rating Scale.

Exclusion criteria

Exclusion criteria: Patients with Comorbidity of depression and Agoraphobia Patients with other Psychiatric disorders. Patients with Uncontrollled Systemic comorbidity. Suspected Immunocompromised individuals. Pregnant and lactating Female. Patient on medication for psychiatric complaints or Herbal medicines.

Design outcomes

Primary

MeasureTime frame
Outcome assessment will be done based on the improvement of signs and symptoms of Generalized Anxiety Disorder at end of treatment and pre and post score of Hamilton Anxiety Rating Scale Timepoint: Duration of study 18 months. Duration of each case is each case will be studied upto 8 months. Duration of follow up of each case 15 days or earlier if required. Clinical outcome assessment will be done at base line of 1 month 4 month and 8 months.

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDR UTTARA AGALE

DR G D POL FOUNDATION YMT HOMOEOPATHIC MEDICAL COLLEGE HOSPIATL AND PG INSTITUTE

uttaraagale@gmail.com9850869404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026